About Oncosimis
Developer of proprietary technology platforms for manufacturing bio-therapeutic proteins and biosimilars. It focuses on developing and producing bio-therapeutic proteins using two proprietary technology platforms. These platforms provide a distinctive advantage in manufacturing biosimilars at an affordable cost. The company has leveraged a team of experienced research scientists, doctors, and entrepreneurs in the field of drug discovery, towards manufacturing and commercializing bio-therapeutics and recombinant proteins.
- Headquarter Hyderabad, India
- Founders Sridhar Kunchala
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oncosimis Biotech Private Limited
- Date of Incorporation 05 Dec, 2016
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$283.44 K (USD)-23.8as on Mar 31, 2023
-
Net Profit
$29.69 K (USD)-77.04as on Mar 31, 2023
-
EBITDA
$4.4 K (USD)-97.65as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oncosimis
Detailed funding history for Oncosimis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncosimis
Investment portfolio details for Oncosimis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oncosimis
Detailed financials for Oncosimis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncosimis Comparisons
Peer comparison for Oncosimis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncosimis
Detailed competitors of Oncosimis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncosimis
Complete news archive for Oncosimis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncosimis
Oncosimis was founded in 2016.
Oncosimis is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Oncosimis is $283.44K as on Mar 31, 2023.
Developer of proprietary technology platforms for manufacturing bio-therapeutic proteins and biosimilars. It focuses on developing and producing bio-therapeutic proteins using two proprietary technology platforms. These platforms provide a distinctive advantage in manufacturing biosimilars at an affordable cost. The company has leveraged a team of experienced research scientists, doctors, and entrepreneurs in the field of drug discovery, towards manufacturing and commercializing bio-therapeutics and recombinant proteins.